ProPhase Labs Inc. has announced the appointment of Carolina Abenante as an independent director on its Board, filling an existing vacancy. Additionally, Ms. Abenante has been appointed as a member of the Nominating and Corporate Governance Committee and as Chair of the Compensation Committee. These appointments are effective from June 20, 2025, with her term set to expire at the Company's annual meeting on July 18, 2025, where she has been nominated for re-election. Ms. Abenante brings extensive experience in technology and advertising, having founded NYIAX, Inc. and held various leadership roles in the industry.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-016501), on June 25, 2025, and is solely responsible for the information contained therein.
Comments